Results 11 to 20 of about 75,591 (303)

Opioid use disorder [PDF]

Nature Reviews Disease Primers, 2020
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse.
Volkow, Nora D, Koob, George F, Marshall, Brandon D.L., Hickman, Matthew, Johnson, Kimberly, Strang, John, Walsh, Sharon L, Tyndall, Mark, Degenhardt, Louisa, Koob, George F., Volkow, Nora D., Walsh, Sharon L., Marshall, Brandon D L   +12 more
core   +8 more sources

Opioid use disorder in pregnancy [PDF]

Mental Health Clinician, 2019
AbstractThe number of pregnant people affected by the opioid epidemic in the United States continues to rise. The following key aspects of opioid use disorder in pregnancy are explored through the progression of a pregnancy via a patient case: treatment options, treatment decisions, substance use screening, dosing modifications, and other aspects of ...
Anshula, Ambasta, Mary, Malebranche
openaire   +5 more sources

Comorbid Opioid Use Disorder in Body Dysmorphic Disorder

European Psychiatry, 2022
Introduction Body Dysmorphic Disorder (BDD) is a severe and common disorder that consists of distressing or impairing preoccupation with nonexistent or slight flaws in one’s physical appearance.
J. Kim, O. Alli-Balogun, G. Gill, P. Korenis, S. Mitra   +4 more
doaj   +1 more source

Use and Outcomes of Medication for Opioid Use Disorder Among Patients With Opioid Use Disorder Undergoing Surgery

Annals of Surgery Open
Objective:. We examined patterns of use of perioperative medication for opioid use disorder (MOUD) in patients undergoing surgical procedures and assessed the association between MOUD use and perioperative opioid use and postsurgical adverse events ...
Alicia H. Li, MD, Yongmei Huang, MD, DrPH, Silvia S. Martins, MD, PhD, Yukio Suzuki, MD, PhD, Jennifer S. Ferris, PhD, Xiao Xu, PhD, Dawn L. Hershman, MD, Jason D. Wright, MD   +7 more
doaj   +2 more sources

Attending a Biopsychosocially Focused Buprenorphine Training Improves Clinician Attitudes

Frontiers in Psychiatry, 2021
Objective: Substance use disorders remain highly stigmatized. Access to medications for opioid use disorder is poor. There are many barriers to expanding access including stigma and lack of medical education about substance use disorders. We enriched the
Holly Ann Russell, Brian Smith, Mechelle Sanders, Elizabeth Loomis   +3 more
doaj   +1 more source

Prevalence and predictors of suicidality among adults initiating office-based buprenorphine

Addiction Science & Clinical Practice, 2023
Background Individuals who have substance use disorders may have an elevated risk of suicidality. This study sought to examine the prevalence of, and identify factors associated with, suicidality in adults with opioid use disorder (OUD) initiating office-
Michelle R. Lent, Karen L. Dugosh, Emily Hurstak, Hannah R. Callahan, Kimberly Mazur, The Greater Philadelphia Opioid Use Disorder Research Group   +5 more
doaj   +1 more source

Patient evaluation of a smartphone application for telehealth care of opioid use disorder

Addiction Science & Clinical Practice, 2022
Background People with opioid use disorder (OUD) face barriers to entering and remaining in life-saving treatment (e.g., stigma, detrimental interactions with health care, and privacy concerns).
Jordon D. Bosse, Kim Hoffman, Katharina Wiest, P. Todd Korthuis, Ritwika Petluri, Kellie Pertl, Stephen A. Martin   +6 more
doaj   +1 more source

Opioid Use Disorders [PDF]

Child and Adolescent Psychiatric Clinics of North America, 2016
Opioid use and addiction in adolescents and young adults is a health problem of epidemic proportions, with devastating consequences for youth and their families. Opioid overdose is a life-threatening emergency that should be treated with naloxone, and respiratory support if necessary.
Bikash, Sharma, Ann, Bruner, Gabrielle, Barnett, Marc, Fishman   +3 more
openaire   +2 more sources

U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study

SAGE Open Medicine, 2021
Background: Of the over 20 million Americans reporting an opioid use disorder, only around 3 million report receiving treatment of any kind. The gold standard for opioid use disorder treatment is medication in combination with psychosocial support, but ...
Kenneth C Hohmeier, Alina Cernasev, Megan Sensmeier, Elizabeth Hall, Katie Webb, Rachel Barenie, Gerald Cochran   +6 more
doaj   +1 more source

Opioid Use Disorder [PDF]

North Carolina Medical Journal, 2018
The current opioid epidemic is devastating to the lives of individuals, families, and communities, but there are effective treatment approaches available. Treatment that combines proven medications with behavioral therapies and other supports is giving many in North Carolina the opportunity to engage in successful recovery.
Smith, Worth, Kenny, House
openaire   +4 more sources